RSS Feed This entry was posted on Tuesday, November 17th, 2009 at 4:30 pm and is filed under FYI. You can leave a response, or trackback from your own site.
 |
- At Other Sites
- Beam Me Up
- Book Review
- Breaking News
- CBO
- Discussion
- From the Trenches
- FYI
- Ground Control to Sen. Democrats
- Health Alert
- 2008 Election
- African AIDS
- Babies
- Bad Studies
- Book Reviews
- Bush Health Plan
- Diabetics
- Drugs
- Health Care Access
- Health Care Costs
- Health Reform
- HSAs
- International
- LAZIK Surgery
- Malpractice
- Media Advisory
- Medicaid
- Medical Economics
- Medical Tourism
- Mental Health
- Minimum Wage
- Portability
- Racial Disparities
- RAND Studies
- Safety
- Scary Forecasts
- SCHIP
- Seniors/Medicare
- Socialized Medicine
- Supply Side
- Telemedicine
- Transparency
- Uninsured
- Vet Care
- Vision Thing
- Workers Comp
- Hits & Misses
- Holiday
- In Memoriam
- In the News
- Interesting Videos
- Memorial Day
- New Videos
- NHS Update
- Notable and Quotable
- Obesity Update
- On Capitol Hill
- Personal Testimony
- Petition
- Plans
- Policy Update
- Question of the Week
- Quote of the Day
- Season's Greetings
- Song of the Season
- The People Speak Out
- Updates
Categories
Contributors
- Ron Bachman
- Michael Bond
- Jim Frogue
- John Goodman
- Linda Gorman
- Robert Graboyes
- John R. Graham
- Devon Herrick
- Regina Herzlinger
- June O'Neill
- Roy Ramthun
- Greg Scandlen
Recent Posts
- CIGNA CDHC Results
- No Reduction in Crashes After Cell Phone Bans, Stress Hormone May Treat Diabetes, and High Deductible Health Plans
- An Argument Against the New Mental Health Parity Law
- Exercising Keeps Your Cells from Aging
- Why are There Collectivists?
- Obama’s Spending Freeze, Virginia Makes It Illegal to Require Insurance, and Lancet’s Vaccine Retraction
- Super Bowl Weekend
- Employer Selection of Health Plans for Employees is Wasteful
- Study: Sitting Kills
- Posner and Becker on Obama’s Job Subsidy Plan
Blogroll
Nov 17, 2009
Companies waste many millions going down experimental paths that their competitors have already found to be dead ends… M.I.T. is proposing dead-end drug disclosure, a concept for drug makers to share information about compounds they have tried and shelved, for reasons like toxicity or inefficacy.
Full New York Times article here.
5 Responses to “Should Drug Companies Disclose Their Research Failures?”
RSS
Twitter
YouTube
LinkedIn
Facebook
Flickr
Helium
November 17th, 2009 at 5:45 pm
Very interesting. They may need to develop some cooperaive strategies, now that they are going to have more intrusive government breathing down their neck.
November 17th, 2009 at 6:14 pm
Is there an anti trust issue here?
November 17th, 2009 at 7:07 pm
Larry, I would think there would be. The only way to keep people honest is to make the agreement contractual, with penalties for failure to comply.
November 18th, 2009 at 12:35 pm
The fact a given chemical compound has been tried and failed is proprietary information. Communicating failures has the potential to alert competitors about the types of research being undertaken as well as the potential to help rivals avoid costly mistakes.
November 18th, 2009 at 2:19 pm
The answer to your question is “yes.”